Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study. [electronic resource]
Producer: 20150225Description: 1-9 p. digitalISSN:- 1536-3678
- Adolescent
- Anemia, Sickle Cell -- blood
- Child
- Child, Preschool
- Female
- Humans
- Male
- Models, Biological
- Piperazines -- adverse effects
- Platelet Aggregation Inhibitors -- pharmacology
- Prasugrel Hydrochloride
- Purinergic P2Y Receptor Antagonists -- pharmacokinetics
- Research Design
- Thiophenes -- adverse effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.